Similarly, a recent study, using high-resolution mass spectrometry, showed lower total ceramides, and particularly reduced levels of CER 14:0, 16:0, and 18:0 species, in placentae from GDM vs. non-GDM pregnancies [37]. This evidence concerns the gene CBLN1 and gestational diabetes.